The Column Group
The Column Group

The Column Group

Measured by AhrefsDR34 out of 100, Below median. Ahrefs DR. Open the scores section.Ahrefs DR: 34/100. Below median. Measured by Ahrefs. Median 44.

A science-driven venture capital firm building early-stage biotechnology companies focused on drug discovery.

2007VC43 portfolio$4.0B AUMSan Francisco, United States
Rate

About

The Column Group (TCG) is a venture capital firm dedicated to creating the next generation of biotechnology companies. TCG focuses on early-stage drug discovery, investing in disease-focused companies with the potential to become leaders in their respective fields. The firm employs an edge-to-edge investment model, supporting companies from inception through exit, and emphasizes a hands-on approach to company building.

Scores

Measured, not editorial

34

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Below median

Check yours

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Get notified when The Column Group changes

Raised from The Column Group, or pitched them? Review them for other founders

Founders pick investors on what other founders say. Your first review on StartupHub.ai also adds $5 in credits (1,250) to your account.

Frequently asked

When did The Column Group last invest?

The most recent round we track is InduPro's Series B in August 2026.

What companies has The Column Group invested in?

The Column Group has invested in InduPro, Tortugas Neuroscience, Tenaya Therapeutics, Hexagon Bio, SyntheX and 38 more.

What stage does The Column Group invest in?

The Column Group invests at Seed, Early Stage Venture, Later Stage Venture, Post-IPO, Early Stage and Later Stage.

What sectors does The Column Group invest in?

The Column Group focuses on Life Sciences, Healthcare, Biotechnology, Drug Discovery, Oncology and Inflammation.

Does The Column Group lead rounds?

Yes. The Column Group led 1 of the 8 rounds we track.

Who are the partners at The Column Group?

The The Column Group team we track includes Carla Daniel (Partner & Chief People Officer), James Evangelista (Partner & Chief Financial Officer), Tim Kutzkey (Managing Partner) and Sarah Hymowitz (Partner), 9 people in all.

SEC filings, insider activity, nonprofit links and pay benchmarks for The Column Group:

Team (9)
Free account: up to 500 email reveals a month
Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Get The Column Group found by the founders raising now

Founders research investors here and in AI answers before they pitch. StartupHub.ai has 100,000+ visitors a month and new startups every day. Max Agent keeps The Column Group ranking where they look.

What it does for The Column Group

$79 a month, or $9.99 with our badge on your site

  • Checked every week: do ChatGPT, Claude, Perplexity and Gemini name The Column Group for searches like "Life Sciences investors"
  • Profile, portfolio and team kept current from your site, the news and filings
  • A post for your blog every week, on your thesis and portfolio, ready to publish
  • Every change sent to Bing, and Google checked daily
  • A Monday report of what it did and what moved